Preflex cleaning solution Új-Zéland - angol - Medsafe (Medicines Safety Authority)

preflex cleaning solution

alcon laboratories australia pty ltd (nz) - disodium edetate dihydrate 0.2%{relative}; hyetellose 0.792%{relative}; sodium chloride 0.422%{relative} - contact lens solution - active: disodium edetate dihydrate 0.2%{relative} hyetellose 0.792%{relative} sodium chloride 0.422%{relative} excipient: dibasic sodium phosphate monobasic sodium phosphate dihydrate polyvinyl alcohol purified water thiomersal tyloxapol

Soaclens soaking & wetting solution Új-Zéland - angol - Medsafe (Medicines Safety Authority)

soaclens soaking & wetting solution

pacific pharmaceuticals limited (part of mylan) - disodium edetate dihydrate 0.1%{relative}; polysorbate 80 0.05%{relative}; polyvinyl alcohol 0.75%{relative}; sodium chloride 0.458%{relative} - contact lens solution - active: disodium edetate dihydrate 0.1%{relative} polysorbate 80 0.05%{relative} polyvinyl alcohol 0.75%{relative} sodium chloride 0.458%{relative} excipient: dibasic sodium phosphate hyetellose monobasic sodium phosphate dihydrate purified water thiomersal

Soflet Új-Zéland - angol - Medsafe (Medicines Safety Authority)

soflet

morgan and hall ltd - dibasic sodium phosphate 0.018%{relative}; disodium edetate dihydrate 0.01%{relative}; monobasic sodium phosphate dihydrate 0.33%{relative}; sodium chloride 0.827%{relative}; thiomersal 0.002%{relative} - contact lens solution - active: dibasic sodium phosphate 0.018%{relative} disodium edetate dihydrate 0.01%{relative} monobasic sodium phosphate dihydrate 0.33%{relative} sodium chloride 0.827%{relative} thiomersal 0.002%{relative}

Transdrop Új-Zéland - angol - Medsafe (Medicines Safety Authority)

transdrop

smith & nephew ltd - benzalkonium chloride 0.004%{relative} (0.008% as 50% solution); disodium edetate dihydrate 0.02%{relative};  ; polyvinyl alcohol 1.4%{relative} - eye drops, solution - 0.004%/0.02%/1.4% - active: benzalkonium chloride 0.004%{relative} (0.008% as 50% solution) disodium edetate dihydrate 0.02%{relative}   polyvinyl alcohol 1.4%{relative} excipient: hyetellose purified water sodium chloride sodium hydroxide

PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 10mL injection pre-filled syringe Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

primovist disodium gadoxetate 181.43 mg/ml (0.25m) 10ml injection pre-filled syringe

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: water for injections; trisodium caloxetate; trometamol; hydrochloric acid; sodium hydroxide - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 7.5mL injection pre-filled syringe Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

primovist disodium gadoxetate 181.43 mg/ml (0.25m) 7.5ml injection pre-filled syringe

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: trometamol; sodium hydroxide; hydrochloric acid; water for injections; trisodium caloxetate - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 10mL injection vial Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

primovist disodium gadoxetate 181.43 mg/ml (0.25m) 10ml injection vial

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; trisodium caloxetate; water for injections; sodium hydroxide; trometamol - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 7.5mL injection vial Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

primovist disodium gadoxetate 181.43 mg/ml (0.25m) 7.5ml injection vial

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: trisodium caloxetate; sodium hydroxide; trometamol; water for injections; hydrochloric acid - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 5mL injection pre-filled syringe Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

primovist disodium gadoxetate 181.43 mg/ml (0.25m) 5ml injection pre-filled syringe

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; trisodium caloxetate; trometamol; sodium hydroxide - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 5mL injection vial Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

primovist disodium gadoxetate 181.43 mg/ml (0.25m) 5ml injection vial

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: water for injections; trometamol; trisodium caloxetate; hydrochloric acid; sodium hydroxide - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion